Can mango and probiotics tame obesity inflammation? new study investigates

NCT ID NCT07505212

Ongoing Knowledge-focused Sponsor: Prairie View A&M University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at how compounds from mango (gallotannins) and a probiotic called Lactiplantibacillus pentosus affect gut bacteria and inflammation in people with obesity. Researchers will analyze stool samples from 20 participants (lean and obese) after giving them mango juice, probiotic, or both. It is a lab-based study, not a treatment, aiming to understand how these foods interact with the gut microbiome.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Mango juice (gallotannin-rich) and Lactiplantibacillus pentosus probiotic
What this could lead to: If successful, this could point toward dietary strategies to reduce inflammation in obesity by improving gut health.
What could go wrong: This is a very small, early-stage lab study using stool samples, not a treatment trial. Results may not translate to real-world benefits or apply to broader populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY (DISORDER) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OBESITY (DISORDER)

Contacts and locations

Locations

Collaborative Agricultural Research Center

Prairie View, Texas, 77446, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.